Cargando…
Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre
INTRODUCTION: A Cochrane review of seven randomised trials (N=1571) comparing surgery and primary endocrine therapy (PET) (oestrogen receptor (ER) unselected) shows no difference in overall survival (OS). We report outcome of a large series with ER-positive (ER+) early invasive primary breast cancer...
Autores principales: | Syed, B M, Al-Khyatt, W, Johnston, S J, Wong, D W M, Winterbottom, L, Kennedy, H, Green, A R, Morgan, D A L, Ellis, I O, Cheung, K L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101924/ https://www.ncbi.nlm.nih.gov/pubmed/21448163 http://dx.doi.org/10.1038/bjc.2011.105 |
Ejemplares similares
-
Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome
por: Syed, Binafsha Manzoor, et al.
Publicado: (2017) -
Correction: Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome
por: Syed, Binafsha Manzoor, et al.
Publicado: (2018) -
Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro
por: Al-Khyatt, Waleed, et al.
Publicado: (2018) -
Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome
por: Parks, Ruth M., et al.
Publicado: (2020) -
Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)